HomeInsightsMarket Capitalization

Market Capitalization of Suven Pharmaceuticals Ltd

Market Capitalization of Suven Pharmaceuticals Ltd

stocks purchased

₹ 1.6 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

12.8 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

MARKETCAP

₹ 32667.05 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Suven Pharmaceuticals Ltd is ₹ 32667 crore as of 07 Nov 24.
  • The Market Cap of Suven Pharmaceuticals Ltd changed from ₹ 2564 crore on March 2020 to ₹ 17223 crore on March 2024 . This represents a CAGR of 46.37% over 5 years. .
  • The Latest Trading Price of Suven Pharmaceuticals Ltd is ₹ 1283 as of 07 Nov 15:30.
  • The Dividend Payouts of Suven Pharmaceuticals Ltd changed from ₹ 2 on Feb 15, 2022 to ₹ 1 on Sep 09, 2022 . This represents a CAGR of -10.91% over 6 years. .

Historical Market Cap of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Suven Pharmaceuticals Ltd

No data available

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

PRICE

₹ 1283.25

-42.10 (-3.18%)

stock direction

Last updated on: Nov 07 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241283.25
06 Nov 20241325.35
05 Nov 20241333.1
04 Nov 20241319.65
01 Nov 20241328.65
31 Oct 20241315.5
30 Oct 20241274.05
29 Oct 20241278
28 Oct 20241256.9
25 Oct 20241248.3

SWOT Analysis Of Suven Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Suven Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Suven Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Suven Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Suven Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Suven Pharmaceuticals Ltd

No data available

* All values are in

About Suven Pharmaceuticals Ltd

  • Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors.
  • Its services include custom synthesis, process R&D, scale-up and contract manufacturing of intermediates, APIs and formulations.
  • Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Suven Pharmaceuticals Ltd News Hub

News

Suven Pharmaceuticals to conduct EGM

Suven Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

30 Oct 202414:53

News

Suven Pharmaceuticals to convene board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

27 Sep 202410:46

News

Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman

Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chair...

Read more

19 Sep 202419:41

News

Board of Suven Pharmaceuticals approves change in Executive Chairperson

The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on r...

Read more

19 Sep 202419:28

News

Suven Pharmaceuticals to hold board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 Au...

Read more

06 Aug 202417:05

News

Suven Pharmaceuticals to conduct AGM

Suven Pharmaceuticals announced that the 6th Annual General Meeting (AGM) of the company w...

Read more

15 Jul 202417:27

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Suven Pharmaceuticals Ltd Market Cap

What is the market cap of Suven Pharmaceuticals Ltd?

As of November 8, 2024, Suven Pharmaceuticals Ltd has a market capitalization of ₹32667.05, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Suven Pharmaceuticals Ltd's market capitalization?

Suven Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Suven Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Suven Pharmaceuticals Ltd's market capitalization change?

Suven Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*